Evidence map›Paper›PMID 42873461›Full record

ArticleInternational journal of hematology2026

Clinical outcomes of upper-arm port implantation under restrictive platelet transfusion in hematological diseases.

Kazuya Okada, Masato Hisabayashi, Erika Umakoshi, Naoki Takahashi, Reon Inoue, Mio Nashima, Shu Ito, Hitomi Tuchida, Kentaro Nagae, Masatoshi Minakuchi and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Kazuya OkadaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan. ko12315@kchnet.or.jp.ORCID http://orcid.org/0009-0008-1021-245X
Masato HisabayashiDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Erika UmakoshiDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Naoki TakahashiDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Reon InoueDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Mio NashimaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Shu ItoDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Hitomi TuchidaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Kentaro NagaeDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Masatoshi MinakuchiDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Fuyuki MukaizawaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Wataru MurakamiDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Miyui FujiedaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Tomoko ImanakaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Junko NakamuraDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Ryosuke TakayaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Takashi NagayamaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Hiroyuki MuranushiDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Takayuki SatoDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Tatsuhito OnishiDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Yasunori UedaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.
Takeshi MaedaDepartment of Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optimal periprocedural platelet transfusion strategy for implantable central venous port placement in patients with hematological diseases remains unclear. We retrospectively evaluated outcomes after upper-arm port implantation under a restrictive platelet transfusion strategy, with prophylactic platelet transfusion only given at counts < 20 × 10

Indexed as

Central venous accessHematological diseasesPlatelet transfusionThrombocytopeniaUpper-arm port

Identifiers

PMID42873461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.